UBX: Unity Biotechnology, Inc. Operatsion rentabellik

Unity Bio (UBX) kompaniyasining korporativ logotipi

Unity Biotechnology qarishga qarshi kurashish uchun senolitiklar ishlab chiqadi, bunda mustahkam patent himoyasi va qarzdorliksiz balans hisobotidan foydalanadi. Organizmda qarigan hujayralarni tozalashga mo‘ljallangan innovatsion platformasi ushbu terapiya uchun monopol maqomini va’da qilmoqda. GURU.Markets tomonidan o‘tkazilgan operatsion daromadlilik bahosi ushbu grafikni taqdim etadi, bunda 0.00 ushbu maxsus baholash parametrini tavsiflaydi. Kompaniya hozirda cheklangan likvidlik tufayli strategik R&D hamkorlarini qidirmoqda.

Unity Biotechnology, Inc. (UBX): Operatsion rentabellik 04.07.2022dan 19.07.2025gacha

Unity Biotechnology, Inc. (UBX) boʻyicha maʼlumotlarning jamlanma tahliliy kesimlari

Kompaniyaning fundamental tahlili:Unity Biotechnology Inc.
unitybiotechnology.com tayyor mahsulotlari

Operatsion marja soliqlar va foiz majburiyatlarini hisobga olishdan oldin xarajatlarni boshqarish samaradorligini namoyish etgan holda, umumiy daromadga nisbatan asosiy operatsiyalardan olingan foyda ulushini o'lchaydi. Tijorat mahsulotlariga ega bo'lmagan va raqobatlashish uchun klinik sinovlarga tayanadigan Unity Biotechnology (UBX) uchun operatsion rentabellik tendentsiyasi patentlarni himoya qilish jarayonida kapitalning sarflanish sur'ati ko'rsatkichi vazifasini o'taydi.

Asosiy raqobatchilar

Sotuvning operatsion marjasi TEM|QGEN - Operatsion foyda bo'yicha marjinallik|Operatsion marja IONS|RGEN - Sotuvning operatsion rentabelligi|Operatsion rentabellik Avidity RNA|Operatsion marja CRISPR Therapeutics Corp CRSP|GeneDx Corp - Operatsion marja|Ultragenyx Pharma (RARE) - Sotuvning operatsion marjasi|beamtx.com (BEAM) - Operatsion rentabellik|SRPT: Operatsion foyda koeffitsiyenti|Sotuvning operatsion marjasi TWST|TXG - Operatsion foyda bo'yicha marjinallik|Operatsion marja NTLA|Operatsion faoliyat rentabelligi Stoke Therapeutics|Operatsion rentabellik BioLife Solutions BLFS|Wave Life Sciences (WVE) - Sotuvning operatsion rentabelligi|Maze Therapeutics, Inc. - Operatsion marja|Operatsion faoliyat rentabelligi Sionna Therapeutics, Inc. SION|Prime Medicine Bio (PRME) - Operatsion rentabellik|TSHA: Operatsion foyda koeffitsiyenti|Operatsion rentabellik uniQure Pharma|MGTX - Operatsion foyda bo'yicha marjinallik|Operatsion marja RGNX|Operatsion rentabellik SLDB (Solid Biosciences)|Ocugen Corp - Sotuvning operatsion marjasi|PACB: Operatsion foyda bo'yicha sotuv rentabelligi|benitec.com - Operatsion marja|DSGN - Operatsion marja|RCKT: Operatsion marja|FDMT (4D Molecular Therapeutics Inc) - Operatsion rentabellik|Sotuvning operatsion marjasi LXEO|Operatsion rentabellik KRRO|Operatsion marja EDIT|SLN - Sotuvning operatsion rentabelligi|Operatsion marja PRQR (ProQR)|CDXS - Sotuvning operatsion marjasi|Sangamo Therapeutics Inc. - Operatsion marja|NAUT - Operatsion marja|MGX: Operatsion marja|Sotuvning operatsion marjasi Precision BioSciences, Inc.|GBIO (Generation Bio) - Operatsion marja|Boundless Bio Inc. (BOLD) - Operatsion faoliyat rentabelligi|Sotuvning operatsion marjasi XCUR (exicuretx.com)|Imunon Inc - Operatsion foyda bo'yicha sotuv rentabelligi|Operatsion marja PHIO (Phio Pharmaceuticals Corp)|Operatsion foyda normasi MBIO|RNAZ - Operatsion rentabellik|Operatsion foyda normasi BNGO (bionanogenomics.com)|Applied DNA Sciences (APDN) - Operatsion rentabellik|Bluebird Bio - Operatsion foyda normasi|IPA (ImmunoPrecise Antibodies Ltd) - Operatsion marja|Sotuvning operatsion rentabelligi Omega Therapeutics, Inc. OMGA|Operatsion marja OMIC|RGLS (Regulus Therapeutics Inc.) - Operatsion foyda normasi|Operatsion marja SYRS (Syros Pharmaceuticals Inc.)|Operatsion foyda koeffitsiyenti TBIO (Codex DNA)|TCON - Operatsion rentabellik